has this been posted yet?
They ran a worldwide Monkey Pox pandemic simulation last year
https://www.nti.org/wp-content/uploads/2021/11/NTI_Paper_BIO-TTX_Final.pdf
You gotta be shitting me
Ok, I figured if my usually late to the party ass knew about it, anons on here might've already known. Just thought I'd post it just in case. Carry on
This is the vaccine the US Government just bought
>The Us has ordered 13 million additional doses of the monkeypox vaccine after a Massachusetts man contracted the rare — but potentially severe — virus, officials said Thursday.
>The massive $119 million order of Jynneos jabs — which can be used to treat both the monkeypox virus and smallpox — was created by the biotechnology company Bavarian Nordic, according to Newsweek.
>In 2015, the Centers for Disease Control and Prevention and the Food and Drug Administration approved the use Jynneos as a vaccine for the rare virus.
https://nypost.com/2022/05/19/us-buys-millions-of-monkeypox-vaccines-after-massachusetts-case/
>Bavarian Nordic
NIH Gave funding to Monkey Pox Vaccine Maker in 2010
BAVARIAN NORDIC RECEIVES NIH GRANT TO INVESTIGATE THE POTENTIAL OF AN MVA-BN® BASED VACCINE AGAINST EBOLA AND MARBURG VIRUSES
KvistgĂĄrd, Denmark, October 13, 2010 - Bavarian Nordic A/S (OMX: BAVA) announced today that the company has received funding from the U.S. National Institutes of Health (NIH) to advance its early research in filoviruses (Ebola and Marburg virus).
As previously announced, the company is investigating the potential use of its core vaccine technology, MVA-BN® as a combined vaccine encoding genes for both the Ebola and Marburg strains. The funding from NIH will support an animal efficacy study performed in non-human primates.
Upon evaluation of the initial data from this study, which are expected next year, Bavarian Nordic will determine the future of this project in the company's pipeline.
Bavarian Nordic's President & CEO, Anders Hedegaard commented: "This research grant is yet another sign of the continued strong relationship between Bavarian Nordic and the US government. We have already successfully advanced the development our IMVAMUNE® smallpox vaccine under a fully-funded programme from the US government and with continued support and funding from the US authorities, we are committed to developing innovative vaccines against other potential biological weapons like anthrax, Ebola and Marburg as well. Also, with this initiative we fulfil part of our short term goal to investigate new opportunities to expand the pipeline within our Infectious Disease Division."
bavarian-nordic.com/investor/news/news.aspx?news=1934
>good dig
It gets worse friend…
Peter Daszak, the guy who funded the Wuhan Lab shit for Fauci, wrote a paper in 2020 about "preventing" other pandemics. Including… drumroll please… MONKEYPOX.
A strategy to prevent future epidemics similar to the 2019-nCoV outbreak
He offers three steps to help prevent another pandemic
>Here, we propose three key steps to helping reduce the risk of a future epidemic similar to that caused by the novel coronavirus 2019-nCoV:
In step three he references Monkeypox
>3)
Improve biosecurity of the wildlife trade and animal markets
The wildlife trade has clearly played a role in the emergence of 2019-nCoV, as well as previous diseases in China (SARS) and across the world (e.g. monkeypox in the USA, Ebola in Africa, salmonellosis in the USA and Europe).
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144510/
The ebola part is interesting because Bavarian Nordic, the monkeypox vaccine maker got its money from the NIH for ebola. The links between Daszak and Bavarian Nordic don't just end there though
1/2
Peter Daszak and Henrik Birk of Bavarian Nordic spoke on the same panel about bioweapons being released in the United States in 2018
MEETING OF THE BLUE RIBBON STUDY PANEL ON BIODEFENSE TO ADDRESS DEVASTATING ECONOMIC, CORPORATE, AND FINANCIAL CONSEQUENCES OF A BIOLOGICAL ATTACK AGAINST THE U.S.
Panelists Include U.S. Senators Ron Johnson (R-WI) and Bob Casey (D-PA); also Peter Daszak of EcoHealth Alliance and Henrik Birk of Bavarian Nordic
WASHINGTON, D.C. (July 26, 2018) – Business leaders, U.S. Senators, and other experts will gather at the U.S. Chamber of Commerce in Washington, D.C. on July 31 to discuss the impacts of large-scale biological events on business, finance, and the American economy. The transnational spread of disease can have huge, long lasting economic impacts, draining the coffers of local, tribal, territorial, and state budgets as much as they do federal resources. The bipartisan Blue Ribbon Study Panel on Biodefense is working to change the way America defends against biological threats. This public special focus meeting will take a closer look at the cost of resilience and foster greater dialogue about public and private sector stakeholders to determine how they can work together to address the threat. “We know unequivocally that terrorists have the desire to create and use pathogens as weapons,” said Panel Member and former Representative Jim Greenwood, who is chairing this special focus meeting. “The Director of National Intelligence reiterates this point before Congress year after year. Globalization has empowered the modern bioterrorist. While some in the business community understand the need to address the biological threat, too few have taken steps to prepare for the spread of diseases that could bring their business operations to a halt and result in significant financial losses.”
The meeting will feature a prestigious panel of experts, including United States Senator Ron Johnson (R-WI), Chairman, Senate Committee on Homeland Security and Governmental Affairs, and Senator Bob Casey (D-PA), Co-Chair, Senate Weapons of Mass Destruction Terrorism Caucus and Member, Senate National Security Working Group. Also speaking will be Peter Daszak, President, EcoHealth Alliance and Henrik Birk, COO, Bavarian Nordic. The meeting is set to begin at 10 a.m. Tuesday, July 31, at the U.S. Chamber of Commerce, 1615 H Street, NW, Washington, D.C. The complete agenda can be found here. Your coverage is welcome. Media should RSVP to either attend the event or watch a live stream by contacting steve@SRACommunications.com.
About the Blue Ribbon Study Panel on Biodefense
The Blue Ribbon Study Panel on Biodefense was established in 2014 to conduct a comprehensive assessment of the state of U.S. biodefense efforts, and to issue recommendations to foster change. The Panel’s 2015 report, A National Blueprint for Biodefense: Leadership and Major Reform Needed to Optimize Efforts, identified capability gaps and recommended changes to U.S. policy and law to strengthen national biodefense while optimizing resource investments. The Panel continues to assess biodefense challenges and to urge reform. Former Senator Joe Lieberman and former Governor Tom Ridge co-chair the Panel, and are joined by former Secretary of Health and Human Services Donna Shalala, former Senate Majority Leader Tom Daschle, former Representative Jim Greenwood, and former Homeland Security Advisor Ken Wainstein. Hudson Institute is the Panel’s fiscal sponsor.
https://biodefensecommission.org/meeting-of-the-blue-ribbon-study-panel-on-biodefense-to-address-devastating-economic-corporate-and-financial-consequences-of-a-biological-attack-against-the-u-s/
Only two of those, Abraham Lincoln and Ronald Reagan, are carriers
Jewish religion doesn['t say it's not killing a life. It just permits the killing.
Also, Roe v. Wade does not say you are not killing a life. It just permits it.
Funny how she has a hard time saying "killing"